Literature DB >> 34268228

Public Health Awareness and Knowledge Dissemination Essentially Becomes a Need of the Hour in Combating COVID-19.

Sivaraman Dhanasekaran1, Pradeep Pushparaj Selvadoss1, Sundar Manoharan Solomon2, Ramachandra Bhat Chandramouliswaran3, Leela Kagithakara Vajravelu4, V Venugopal Venkatesalu5.   

Abstract

Entities:  

Year:  2020        PMID: 34268228      PMCID: PMC8266001          DOI: 10.18502/ijph.v49iS1.3692

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

The pandemic spread of severe acute respiratory syndrome coronavirus (SARS-CoV-2) that causes COVID-19 (Coronavirus Disease-2019) made a pathetic travel between Jan to Feb 2020 at Wuhan City, Hubei Province, China (1). Alarming demographic data’s issued by WHO reveals that nearly 83,652 cases have been reported with corona infection globally until 28 February 2020 (2). Among eastern Mediterranean regions Iran surprisingly striking highest transmission rate of 245 cases on the invasion of COVID-19. Each infected person can able to transmit the disease to minimum of two others with the predicted reproductive number of 2.2 (3). SARSCoV-2 as now becomes a major burden on public health and economic stability of societies around the globe. Hence in the present scenario knowledge, dissemination and public health awareness essentially become a need of the hour in combating the COVID-19. Health care providers are constantly striving towards the evidence-based data on newer therapeutic opportunities (4), progress on drug discovery (5), clinical trials, source and mode of viral transmission (6), pathogenicity (7) and possible precautionary measure (8) for their clinical interventions. Research and publication forum priorities top on the communication sector as it potentially unites the people of different paradigms under one roof. Even China, ministry of science and technology requested researcher to have priority focus on publishing their results for epidemic prevention of COVID-19 (9). Droplet infection and surface contamination become the primary modes of disease transmission in the severely affected zones. Investigational outcome advocate’s that under favorable condition SARS-CoV-2 virion can able to survive in air atmosphere up to several hours in pathogenic form (10). In this context public health awareness plays a very crucial role in disease prevention and transmission some of which include. 1) Safe usage and careful disposal of contaminants: Sufficient knowledge should be imparted to both public and health care professionals on safe usage and disposal of potential biomedical wastes which includes bodily fluids, gauze, contaminated masks, gloves, head caps, pads, safety suits, syringes, etc., 2) Sanitation Program: Offering standard operating procedures on surface decontamination with suitable disinfectants, self-cleanliness, 3) Patient-Clinician Interface: Enhanced networking among patient and clinician substantially helps in gaining the patient confidence and timely initiation of therapy. In conclusion, clinical management and control of COVID-19 become everyone’s concern and it’s highly possible with full-fledged professional support from clinicians and cooperation from the public domain.
  8 in total

1.  Effects of air temperature and relative humidity on coronavirus survival on surfaces.

Authors:  Lisa M Casanova; Soyoung Jeon; William A Rutala; David J Weber; Mark D Sobsey
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

2.  Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.

Authors:  Xing-Yi Ge; Jia-Lu Li; Xing-Lou Yang; Aleksei A Chmura; Guangjian Zhu; Jonathan H Epstein; Jonna K Mazet; Ben Hu; Wei Zhang; Cheng Peng; Yu-Ji Zhang; Chu-Ming Luo; Bing Tan; Ning Wang; Yan Zhu; Gary Crameri; Shu-Yi Zhang; Lin-Fa Wang; Peter Daszak; Zheng-Li Shi
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

3.  The viral protein corona directs viral pathogenesis and amyloid aggregation.

Authors:  Kariem Ezzat; Maria Pernemalm; Sandra Pålsson; Thomas C Roberts; Peter Järver; Aleksandra Dondalska; Burcu Bestas; Michal J Sobkowiak; Bettina Levänen; Magnus Sköld; Elizabeth A Thompson; Osama Saher; Otto K Kari; Tatu Lajunen; Eva Sverremark Ekström; Caroline Nilsson; Yevheniia Ishchenko; Tarja Malm; Matthew J A Wood; Ultan F Power; Sergej Masich; Anders Lindén; Johan K Sandberg; Janne Lehtiö; Anna-Lena Spetz; Samir El Andaloussi
Journal:  Nat Commun       Date:  2019-05-27       Impact factor: 14.919

4.  Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets.

Authors:  Mathilde Richard; Judith M A van den Brand; Theo M Bestebroer; Pascal Lexmond; Dennis de Meulder; Ron A M Fouchier; Anice C Lowen; Sander Herfst
Journal:  Nat Commun       Date:  2020-02-07       Impact factor: 14.919

Review 5.  Coronaviruses - drug discovery and therapeutic options.

Authors:  Alimuddin Zumla; Jasper F W Chan; Esam I Azhar; David S C Hui; Kwok-Yung Yuen
Journal:  Nat Rev Drug Discov       Date:  2016-02-12       Impact factor: 84.694

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

8.  Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

Authors:  Timothy P Sheahan; Amy C Sims; Sarah R Leist; Alexandra Schäfer; John Won; Ariane J Brown; Stephanie A Montgomery; Alison Hogg; Darius Babusis; Michael O Clarke; Jamie E Spahn; Laura Bauer; Scott Sellers; Danielle Porter; Joy Y Feng; Tomas Cihlar; Robert Jordan; Mark R Denison; Ralph S Baric
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.